Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 2/20 | 0.36 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 11/20 | 0.35 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.32 |
| ▸ | TRPC6 | Q9Y210 | 1/20 | 0.32 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3326368 | 0.76 | SCD (0.46) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL3323446 | 0.75 | SIRT6 (0.43) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL3323243 | 0.73 | FFAR4 (0.40) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL3323838 | 0.72 | SCD (0.50) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL3320117 | 0.72 | SCD (0.38) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL22138881 | 0.70 | KDM4E (0.36) | CHEK1 | |
| SCHEMBL8297680 | 0.70 | CYP1A2 (0.44) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL3862181 | 0.69 | SCD (0.46) | SCDSCD5 | |
| SCHEMBL10039708 | 0.69 | FFAR1 (0.47) | SCDSCD5FFAR1FFAR4 | |
| SCHEMBL31040072 | 0.69 | FFAR1 (0.47) | SCDSCD5FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100120784-A1 | NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | MERCK FROSST CANADA LTD. (CA) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120784-A1 | NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | SCD, SCD5, ACSL6 | SCD 1/4885SCD5 2/4885FFAR1 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.